Prognostic impact of TID in regadenoson MPI: Some patients and certain events.
Cardiovascular Division and the Cardiac Imaging Center, Department of Medicine, University of Virginia Health System, Box 800158, 1215 Lee Street, Charlottesville, VA, 22908, USA. al2ys@hscmail.mcc.virginia.edu.
Adrián I
AI
Löffler
Cardiovascular Division and the Cardiac Imaging Center, Department of Medicine, University of Virginia Health System, Box 800158, 1215 Lee Street, Charlottesville, VA, 22908, USA.|Department of Radiology, University of Virginia Health System, Charlottesville, VA, USA.
Jamieson M
JM
Bourque
D003324:Coronary Artery Disease; D005080:Exercise Test; D006801:Humans; D055414:Myocardial Perfusion Imaging; D011379:Prognosis; D011687:Purines; D011720:Pyrazoles; D015899:Tomography, Emission-Computed, Single-Photon
D011687:Purines; D011720:Pyrazoles; C430916:regadenoson